Rational prescribing for children

British Medical Journal

Volumn 332, Issue 7556, 2006, Pages 1464-1465

  Sutcliffe, Alastair G ^a   Wong, Ian Chi Kei ^b,c  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b Department of Paediatric Medicines Research ^*

^c UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; MELATONIN; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; BREATH ANALYSIS; CARBOHYDRATE DIET; CHILD HEALTH CARE; CLINICAL TRIAL; COGNITIVE THERAPY; DEPRESSION; DRUG EFFICACY; DRUG LABELING; DRUG USE; EDITORIAL; EUROPE; FOOD AND DRUG ADMINISTRATION; GENERAL PRACTITIONER; HUMAN; IONTOPHORESIS; JOB SATISFACTION; LAW; MEDICAL DECISION MAKING; MEDICAL PRACTICE; OBESITY; PRESCRIPTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SALIVA ANALYSIS; SLEEP DISORDER; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; SUICIDE ATTEMPT; SYSTEMATIC REVIEW; UNITED STATES; CHILD; CLINICAL PRACTICE; DRUG THERAPY; PUBLICATION;

CHILD; DRUG THERAPY; FORMULARIES; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG;

EID: 33745727493     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.332.7556.1464     Document Type: Editorial

References (12)

1. Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, Rane A, et al for the European Network for Drug Investigation in Children. Survey of unlicensed and off label drug use in paediatric wards in European countries. BMJ 2000;320:79-82.
2. National Institute for Health and Clinical Excellence. Depression in children: identification and management of depression in children and young people in primary care and specialist services. Second draft for consultation. www.nice.org.uk/pdf/Depn_child_2ndcons_%20App_P.pdf (accessed 19 Jun 2006).
3. Wong ICK, Besag FMC, Santosh P, Murray ML. Use of selective serotonin reuptake inhibitors in children and adolescents. Drug Safety 2004;27:991-1000.
4. Olfson M, Blanco C, Liu L, Moreno C, Laje G. National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Arch Gen Psychiatry 2006;63:679-85.
5. Wong ICK, Murray ML, Novak-Camilleri D, Stephens P. Increased prescribing trends of paediatric psychotropic medications. Arch Dis Child 2004;89:1131-2.
6. Yanovski SZ. Pharmacotherapy for obesity-promise and uncertainty. N Engl J Med 2005;353:2187-9.
7. Moynihan R. Expanding definitions of obesity may harm children. BMJ 2006;332:1412.
8. Sutcliffe AG. Testing new pharmaceutical products in children. BMJ 2003;326:64-5.
9. US Food and Drug Administration. The Pediatric Research Equity Act. Public Law 108-155 December 3, 2003. www.fda.gov/cder/pediatric/S-650-PREA.pdf (accessed 19 Jun 2006).
10. Watson R. EU offers incentives to firms to produce medicines for children. BMJ 2006;332:1352.
11. Royal College of Paediatrics & Child Health. Safer and better medicines for children-developing the clinical and research base of paediatric pharmacology in the United Kingdom. London: RCPCH Publications, 2004.
12. British Medical Association, Royal Pharmaceutical Society of Great Britain, Royal College of Paediatrics & Child Health, Neonatal and Paediatric Pharmacists Group. BNF for children. London: Pharmaceutical Press, 2005.